"Tachypnea" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased RESPIRATORY RATE.
| Descriptor ID |
D059246
|
| MeSH Number(s) |
C08.618.961 C23.888.852.944
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tachypnea".
Below are MeSH descriptors whose meaning is more specific than "Tachypnea".
This graph shows the total number of publications written about "Tachypnea" by people in this website by year, and whether "Tachypnea" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 4 | 5 |
| 2018 | 0 | 2 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 4 | 5 |
| 2021 | 0 | 6 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Tachypnea" by people in Profiles.
-
Predictors of severity and mortality among patients hospitalized with COVID-19 in Rhode Island. PLoS One. 2021; 16(6):e0252411.
-
Non-intubated COVID-19 patients despite high levels of supplemental oxygen. Crit Care. 2021 05 17; 25(1):170.
-
SARS-CoV-2 RNAaemia in children: An Iranian referral hospital-based study. J Med Virol. 2021 09; 93(9):5452-5457.
-
Saddle pulmonary embolism in a pediatric patient with nephrotic syndrome and recent COVID-19 pneumonia: A case report. Am J Emerg Med. 2021 10; 48:376.e1-376.e2.
-
Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey. Pediatr Rheumatol Online J. 2021 Mar 16; 19(1):29.
-
Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy. JAMA Netw Open. 2021 03 01; 4(3):e211085.
-
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Trials. 2021 Jan 11; 22(1):42.
-
Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India. Monaldi Arch Chest Dis. 2020 Nov 09; 90(4).
-
SARS-CoV-2 infection in an infant with severe dilated cardiomyopathy. Cardiol Young. 2021 Mar; 31(3):485-487.
-
Reversible splenial lesion syndrome associated with SARS-CoV-2 infection in two children. Brain Dev. 2021 Feb; 43(2):230-233.